Maria Luisa Maccecchini is President and CEO of Annovis Bio, Inc.. Currently has a direct ownership of 1.1 Million shares of ANVS, which is worth approximately $6.11 Million. The most recent transaction as insider was on Nov 20, 2023, when has been sold 41,186 shares (Common Stock) at a price of $6.07 per share, resulting in proceeds of $249,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.1M
0% 3M change
3.89% 12M change
Total Value Held $6.11 Million

Maria-Luisa Maccecchini Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2023
BUY
Grant, award, or other acquisition
$249,999 $6.07 p/Share
41,186 Added 3.61%
1,098,675 Common Stock
Apr 24 2023
SELL
Bona fide gift
-
3,000 Reduced 0.28%
1,057,489 Common Stock
Apr 07 2023
BUY
Grant, award, or other acquisition
$252,200 $12.61 p/Share
20,000 Added 1.85%
1,060,489 Common Stock
Feb 06 2023
BUY
Exercise of conversion of derivative security
$7,385 $0.14 p/Share
52,755 Added 4.83%
1,040,489 Common Stock
Jan 14 2022
BUY
Exercise of conversion of derivative security
$4,614 $0.14 p/Share
32,959 Added 3.23%
987,734 Common Stock
Oct 11 2021
BUY
Open market or private purchase
$496,980 $27.61 p/Share
18,000 Added 1.81%
976,775 Common Stock

Also insider at

LTRN
Lantern Pharma Inc. Healthcare
MM

Maria Luisa Maccecchini

President and CEO
Berwyn, PA

Track Institutional and Insider Activities on ANVS

Follow Annovis Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANVS shares.

Notify only if

Insider Trading

Get notified when an Annovis Bio, Inc. insider buys or sells ANVS shares.

Notify only if

News

Receive news related to Annovis Bio, Inc.

Track Activities on ANVS